Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis Post author: Post published:March 14, 2024 Post category:uncategorized The performance of two commercial phospho-tau217 (p-tau217) assays. You Might Also Like Out for blood? For routine lab work, the hospital billed her $2,400 November 21, 2023 AI reveals hidden rules of cell neighborhoods in cancer January 8, 2024 Targeting necroptosis could halt nerve cell loss in Alzheimer’s October 31, 2024